Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Coloplast Director's Dealing 2022

Jan 26, 2022

3358_rpt_2022-01-26_81c0a310-cbb9-4428-852d-b6c0c05eba53.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

Coloplast A/S Holtedam 1 3050 Humlebaek Denmark Tel: +45 4911 1111 www.coloplast.com Company reg. (CVR) no. 69749917

Report on transactions of executives and related parties in Coloplast shares and related securities

According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.

The below transaction concerns purchase of shares.

1 Details of the person discharging managerial responsibilities/person closely associated
a) Name Marianne Wiinholt
2 Reason for the notification
a) Position/status Member of the Board of Directors
b) Initial notification/Amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Coloplast A/S (CVR-no.: 69749917)
b) LEI code 529900NN7SOJ5QG82X67
4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been conducted
a) Description of the financial instrument, type of instrument B shares
Identification code ISIN: DK0060448595 (B shares)
b) Nature of the transaction Purchase of shares
c) Price(s) and volume(s) Price(s) Volume(s)
See appendix See appendix
d) Aggregated information
- Aggregated volume 500 shares
- Price DKK 941.36 (volume weighted average)
e) Date of the transaction 2022-01-26, 08:34 UTC (last trade)
See appendix for details
f) Place of the transaction Nasdaq Copenhagen A/S (XCSE)

This information is available in Danish and in English, in case of doubt the Danish version prevails. For further information: Hannah Katrine Larsen, tel.: +45 4911 3616.

Appendix

Date & time (CET) Price(s) Volume(s)
20220126 09:33:33 941.60 100
20220126 09:33:33 941.60 19
20220126 09:33:33 941.20 9
20220126 09:33:33 941.20 61
20220126 09:33:33 941.40 38
20220126 09:33:33 941.80 26
20220126 09:33:33 941.40 22
20220126 09:33:33 941.20 9
20220126 09:33:33 941.60 22
20220126 09:33:33 941.20 23
20220126 09:33:33 941.20 2
20220126 09:33:33 941.00 169

Our mission

Making life easier for people with intimate health care needs

Our values

Closeness... to better understand Passion... to make a difference Respect and responsibility... to guide us

Our vision

Setting the global standard for listening and responding

For further information, please contact

Investors and analysts Press and media Address

Anders Lonning-Skovgaard Executive Vice President, CFO Tel. +45 4911 1111

Ellen Bjurgert Vice President, Investor Relations Tel. +45 4911 1800 /+45 4911 3376 Email: [email protected]

Aleksandra Dimovska Sr. Manager, Investor Relations Tel. +45 4911 1800 / +45 4911 2458 Email: [email protected]

Dennis Kaysen Sr. Director, Communications Tel. 4911 2608 Email: [email protected]

Coloplast A/S Holtedam 1 DK-3050 Humlebaek Denmark Company reg. (CVR) no. 69749917

Website

www.coloplast.com

This announcement is available in a Danish and an English-language version. In the event of discrepancies, the Danish version shall prevail.

Coloplast develops products and services that make life easier for people with very personal and private medical conditions. Working closely with the people who use our products, we create solutions that are sensitive to their special needs. We call this intimate health care. Our business includes Ostomy Care, Continence Care, Wound and Skin Care and Interventional Urology. We operate globally and employ about 12,500 employees.

The Coloplast logo is a registered trademark of Coloplast A/S. © 2022-01. All rights reserved Coloplast A/S, 3050 Humlebaek, Denmark.